Evidence map›Paper›PMID 25806972›Full record

ArticlePloS one2015

ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study.

Jérémie Rudant, Laurent Orsi, Audrey Bonaventure, Stéphanie Goujon-Bellec, André Baruchel, Arnaud Petit, Yves Bertrand, Brigitte Nelken, Marlène Pasquet, Gérard Michel and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Acute lymphoid leukemia etiopathogenesis.Molecular biology reports · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. IKZF1 gene polymorphisms increased the risk of childhood acute lymphoblastic leukemia in an Iranian population.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 14 institutions in 1 country.

Jérémie RudantInstitut national de la santé et de la recherche médicale (INSERM) U1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France; Paris-Descartes University, UMRS-1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Paris, France; French National Registry of Childhood Hematopoietic Malignancies (RNHE), Villejuif, France.
Laurent OrsiInstitut national de la santé et de la recherche médicale (INSERM) U1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France; Paris-Descartes University, UMRS-1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Paris, France.
Audrey BonaventureInstitut national de la santé et de la recherche médicale (INSERM) U1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France; Paris-Descartes University, UMRS-1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Paris, France.
Stéphanie Goujon-BellecInstitut national de la santé et de la recherche médicale (INSERM) U1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France; Paris-Descartes University, UMRS-1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Paris, France; French National Registry of Childhood Hematopoietic Malignancies (RNHE), Villejuif, France.
André BaruchelAssistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Paris, France; Université Paris Diderot-Paris 7, Sorbonne Paris Cité, Paris, France.
Arnaud PetitAssistance Publique-Hôpitaux de Paris, HUEP, Hôpital Trousseau, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMR S_938, Paris, France.
Yves BertrandInstitut d'Hémato-Oncologie Pédiatrique, Lyon, France; Université Claude Bernard Lyon 1, Lyon, France.
Brigitte NelkenPôle Enfant, CHRU, Lille, France; Université Lille Nord de France, Lille, France.
Marlène PasquetHématologie pédiatrique, CHU Toulouse, INSERM U1037, Equipe 16, CRCT, Oncopôle, Toulouse, France.
Gérard MichelDepartment of Pediatric Hematology and Oncology, Timone Enfants Hospital, Marseille, France; Aix-Marseille University, Marseille, France.
Laure SaumetHôpital Arnaud de Villeneuve, Montpellier, France.
Pascal ChastagnerHôpital d'enfants, CHU de Nancy, Vandoeuvre, France.
Stéphane DucassouHôpital Pellegrin Tripode, Bordeaux, France.
Yves RéguerreCHU Félix Guyon, Saint Denis de La Réunion, France.
Denis HémonInstitut national de la santé et de la recherche médicale (INSERM) U1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France; Paris-Descartes University, UMRS-1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Paris, France.
Jacqueline ClavelInstitut national de la santé et de la recherche médicale (INSERM) U1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Epidemiology of childhood and adolescent cancers team (EPICEA), Villejuif, France; Paris-Descartes University, UMRS-1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Paris, France; French National Registry of Childhood Hematopoietic Malignancies (RNHE), Villejuif, France.
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRCentre de Recherche Épidémiologie et StatistiqueCentre Hospitalier Universitaire de La Réunion · FRDélégation Paris 5 · FRDélégation Paris 7 · FRHôpital Arnaud de Villeneuve · FRHôpital de la Timone · FRHôpital d'Enfants · FRHôpital Pellegrin · FRInstitut d’Hématologie et d’Oncologie Pédiatrique · FRSorbonne Paris Cité · FRUniversité Lille Nord de France · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have identified that frequent polymorphisms in ARID5B and IKZF1, two genes involved in lymphoid differentiation, increase the risk of childhood acute lymphoblastic leukemia (ALL). These findings markedly modified the current field of research on the etiology of ALL. In this new context, the present exploratory study investigated the possible interactions between these at-risk alleles and the non-genetic suspected ALL risk factors that were of sufficient prevalence in the French ESCALE study: maternal use of home insecticides during pregnancy, preconception paternal smoking, and some proxies for early immune modulation, i.e. breastfeeding, history of common infections before age one year, and birth order. The analyses were based on 434 ALL cases and 442 controls of European origin, drawn from the nationwide population-based case-control study ESCALE. Information on non-genetic factors was obtained by standardized telephone interview. Interactions between rs10740055 in ARID5B or rs4132601 in IKZF1 and each of the suspected non-genetic factors were tested, with the SNPs coded as counts of minor alleles (trend variable). Statistical interactions were observed between rs4132601 and maternal insecticide use (p = 0.012), breastfeeding p = 0.017) and repeated early common infections (p = 0.0070), with allelic odds ratios (OR) which were only increased among the children not exposed to insecticides (OR = 1.8, 95%CI: 1.3, 2.4), those who had been breastfed (OR = 1.8, 95%CI: 1.3, 2.5) and those who had had repeated early common infections (OR = 2.4, 95%CI: 1.5, 3.8). The allelic ORs were close to one among children exposed to insecticides, who had not been breastfed and who had had no or few common infections. Repeated early common infections interacted with rs10740055 (p = 0.018) in the case-only design. Further studies are needed to evaluate whether these observations of a modification of the effect of the at-risk alleles by non-genetic factors are chance findings or reflect true underlying mechanisms.

Indexed as

AdolescentAllelesCase-Control StudiesChildChild, PreschoolDNA-Binding ProteinsFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansIkaros Transcription FactorInfantInfant, NewbornMalePolymorphism, Single NucleotideARID5B protein, humanDNA-Binding ProteinsIkaros Transcription FactorIKZF1 protein, humanTranscription Factors

Identifiers

PMID25806972
PMCPMC4373901
OpenAlexW2001246529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.